Loading...
•
Sep 30, 2022
Health Catalyst Q3 2022 Earnings Report
Achieved strong performance, exceeded revenue and Adjusted EBITDA guidance, and raised full year 2022 revenue and Adjusted EBITDA guidance.
Key Takeaways
Health Catalyst reported strong Q3 2022 results, exceeding revenue and Adjusted EBITDA guidance. The company raised its full year 2022 revenue and Adjusted EBITDA guidance and expects the dollar-based retention achievement level to be between 97% and 101%.
Total revenue for the quarter was $68.354 million, an 11% increase year-over-year.
Technology revenue was $43.997 million, a 15% increase year-over-year.
Professional services revenue was $24.357 million, a 4% increase year-over-year.
Adjusted EBITDA was $(4.554) million, exceeding the mid-point of quarterly guidance.
Revenue by Segment
Forward Guidance
For the fourth quarter of 2022, Health Catalyst expects total revenue between $66.9 million and $68.9 million, and Adjusted EBITDA between $(2.1) million and $(0.1) million. For the full year of 2022, the company expects total revenue between $274.0 million and $276.0 million, and Adjusted EBITDA between $(4.0) million and $(2.0) million.
Positive Outlook
- Total revenue between $66.9 million and $68.9 million for Q4 2022
- Adjusted EBITDA between $(2.1) million and $(0.1) million for Q4 2022
- Total revenue between $274.0 million and $276.0 million for the full year 2022
- Adjusted EBITDA between $(4.0) million and $(2.0) million for the full year 2022
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...